Nasus Pharma Ltd (NSRX): Cash & Equivalents
Figures out of scale. In this company's filings, reported revenue for the year ended 2025-12-31 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.
$1.24M
As of 2025-12-31. As filed; likely tagged in the wrong unit
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.24M | n/a | 2026-03-25, Balance as of period end |
| 2024-12-31 | $284.0K | n/a | 2026-03-25, Balance as of period end |
| 2023-12-31 | $193.0K | n/a | 2026-03-25, Balance as of period end |